Ending what is arguably the science policy equivalent of Presidents Adams or Johnson serving in Congress following their time in the White House, Dr. Harold Varmus announced he will step down as chief of the National Cancer Institute (NCI) effective March 31st. Varmus was head of the entire National Institutes of Health between 1993 and 1999, meaning he was a predecessor of his current boss, Dr. Francis Collins. Both of these stints in public service came after Varmus was recognized as a 1989 Nobel Laureate in Physiology or Medicine
Varmus highlighted the National Cancer Institute accomplishments during his tenure in a letter to NCI staff. They include two new centers, improvements in its clinical trials program, innovations in research funding and significant changes to the NCI’s grant process.
Varmus will now live full time in New York City (he was commuting to the NCI facility in Bethesda, Maryland), conducting cancer research in his own lab at the Meyer Cancer Center at the Weill-Cornell Medical Center. He is likely to apply for funding for the cancer components of the Precision Medicine Initiative. He will also advise the newly formed New York Genome Center.
The current NCI Deputy Director, Doug Lowy, will serve as Acting Director once Varmus departs. With less than two years remaining in the current administration, it is possible that Lowy will remain in the position until at least the next President is sworn in.